1 Min Read
March 5 (Reuters) - Novo Nordisk A/S:
* NOVO NORDISK - OZEMPIC(®) (SEMAGLUTIDE INJECTION) IS NOW AVAILABLE ACROSS CANADA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.